Skip to main content
Top
Published in: Lung 6/2011

01-12-2011

Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns

Authors: Chin-Chung Shu, Chih-Hsin Lee, Chia-Lin Hsu, Jann-Tay Wang, Jann-Yuan Wang, Chong-Jen Yu, Li-Na Lee, The TAMI Group

Published in: Lung | Issue 6/2011

Login to get access

Abstract

Rationale

The clinical characteristics and prognostic impact of radiographic patterns of patients with nontuberculous mycobacterial lung disease (NTM-LD) are rarely evaluated.

Design

Patients with NTM-LD from 2007 to 2009 in a single medical center in Taiwan were identified. Their radiographic patterns were reviewed and classified into cavitary, bronchiectatic, or consolidative. They were also compared to patients with cavitary pulmonary tuberculosis (TB-LD).

Results

Of 481 NTM-LD patients identified, 62, 134, and 56 patients were categorized into cavitary, bronchiectatic, and consolidative groups, respectively. Compared with 180 TB-LD patients, cavitary NTM-LD had male predominance and was associated with higher grades of sputum acid-fast smear (3+ or 4+), prior pulmonary TB, and poor baseline pulmonary function. NTM-LD patients with consolidative pattern were likely to have underlying comorbidity, the highest blood leukocyte count and C-reactive protein, and lowest albumin. In all NTM-LD, the consolidative pattern was independently associated with poor prognosis for 6-month survival. Patients with cavitary Mycobacterium avium complex (MAC)-LD had worse 6-month survival than those with bronchiectatic pattern.

Conclusion

In Taiwan, NTM-LD patients with consolidative pattern have the worst prognosis while patients with cavitary pattern have worse survival than those with bronchiectasis in MAC-LD. Because varying radiographic patterns represent different prognoses, understanding the characteristics of NTM-LD patients with different radiographic patterns complements clinical practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lai CC, Tan CK, Chou CH et al (2010) Increasing incidence of non-tuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis 16(2):294–296PubMed Lai CC, Tan CK, Chou CH et al (2010) Increasing incidence of non-tuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis 16(2):294–296PubMed
2.
go back to reference Field SK, Cowie RL (2006) Lung disease due to the more common non-tuberculous mycobacteria. Chest 129(6):1653–1672PubMedCrossRef Field SK, Cowie RL (2006) Lung disease due to the more common non-tuberculous mycobacteria. Chest 129(6):1653–1672PubMedCrossRef
3.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416PubMedCrossRef Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416PubMedCrossRef
4.
go back to reference Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S (2007) Disseminated non-tuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 45(4):421–427PubMedCrossRef Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S (2007) Disseminated non-tuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 45(4):421–427PubMedCrossRef
5.
go back to reference Martin-Casabona N, Bahrmand AR, Bennedsen J et al (2004) Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 8(10):1186–1193PubMed Martin-Casabona N, Bahrmand AR, Bennedsen J et al (2004) Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 8(10):1186–1193PubMed
6.
go back to reference Shu CC, Lee CH, Wang JY et al (2008) Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med 34(12):2194–2201PubMedCrossRef Shu CC, Lee CH, Wang JY et al (2008) Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med 34(12):2194–2201PubMedCrossRef
7.
go back to reference Donnabella V, Salazar-Schicchi J, Bonk S, Hanna B, Rom WN (2000) Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved laboratory methods? Chest 118(5):1365–1370PubMedCrossRef Donnabella V, Salazar-Schicchi J, Bonk S, Hanna B, Rom WN (2000) Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved laboratory methods? Chest 118(5):1365–1370PubMedCrossRef
8.
go back to reference Lu D, Heeren B, Dunne WM (2002) Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 118(4):542–545PubMedCrossRef Lu D, Heeren B, Dunne WM (2002) Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 118(4):542–545PubMedCrossRef
9.
go back to reference Koh WJ, Yu CM, Suh GY et al (2006) Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 10(9):1001–1007PubMed Koh WJ, Yu CM, Suh GY et al (2006) Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 10(9):1001–1007PubMed
10.
go back to reference Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J (1998) Clinical features of non-tuberculous mycobacterial disease: comparisons between smear-positive and smear-negative cases, and between Mycobacterium avium and Mycobacterium intracellulare. Int J Tuberc Lung Dis 2(7):597–602PubMed Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J (1998) Clinical features of non-tuberculous mycobacterial disease: comparisons between smear-positive and smear-negative cases, and between Mycobacterium avium and Mycobacterium intracellulare. Int J Tuberc Lung Dis 2(7):597–602PubMed
11.
go back to reference The Research Committee of the British Thoracic Society (2002) Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. Int J Tuberc Lung Dis 6(7):628–634 The Research Committee of the British Thoracic Society (2002) Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. Int J Tuberc Lung Dis 6(7):628–634
12.
go back to reference Wang JY, Hsueh PR, Wang SK et al (2007) Disseminated tuberculosis: a 10-year experience in a medical center. Medicine 86(1):39–46PubMedCrossRef Wang JY, Hsueh PR, Wang SK et al (2007) Disseminated tuberculosis: a 10-year experience in a medical center. Medicine 86(1):39–46PubMedCrossRef
13.
go back to reference Pfyffer GE, Vicent V, Gutiérrez MC, Brown-Elliott BA, Wallace RJ (2007) Myobacterium. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Landry ML (eds) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC, pp 543–600 Pfyffer GE, Vicent V, Gutiérrez MC, Brown-Elliott BA, Wallace RJ (2007) Myobacterium. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Landry ML (eds) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC, pp 543–600
14.
go back to reference American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America (2005) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 172(9):1169–1227 American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America (2005) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 172(9):1169–1227
15.
go back to reference Ralph AP, Ardian M, Wiguna A et al (2010) A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65(10):863–869PubMedCrossRef Ralph AP, Ardian M, Wiguna A et al (2010) A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65(10):863–869PubMedCrossRef
16.
go back to reference Iseman MD, Chan ED (2010) Bronchiectasis. In: Mason RJ, Broaddus VC, Martin TR, King TE, Schraufnagel DE, Murray JF, Nadel JA (eds) Murray and Nadel’s textbook of respiratory medicine, 5th edn. Elsevier, New York, pp 1023–1046 Iseman MD, Chan ED (2010) Bronchiectasis. In: Mason RJ, Broaddus VC, Martin TR, King TE, Schraufnagel DE, Murray JF, Nadel JA (eds) Murray and Nadel’s textbook of respiratory medicine, 5th edn. Elsevier, New York, pp 1023–1046
17.
go back to reference Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Muller NL (2008) Chest radiographic and CT manifestations of chronic granulomatous disease in adults. Am J Roentgenol 191(5):1570–1575CrossRef Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Muller NL (2008) Chest radiographic and CT manifestations of chronic granulomatous disease in adults. Am J Roentgenol 191(5):1570–1575CrossRef
18.
go back to reference Shu CC, Wu HD, Yu MC et al (2010) Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 89(1):53–61CrossRef Shu CC, Wu HD, Yu MC et al (2010) Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 89(1):53–61CrossRef
19.
go back to reference Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968PubMedCrossRef Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968PubMedCrossRef
20.
go back to reference Kim RD, Greenberg DE, Ehrmantraut ME et al (2008) Pulmonary non-tuberculous mycobacterial disease: prospective study of a distinct pre-existing syndrome. Am J Respir Crit Care Med 178(10):1066–1074PubMedCrossRef Kim RD, Greenberg DE, Ehrmantraut ME et al (2008) Pulmonary non-tuberculous mycobacterial disease: prospective study of a distinct pre-existing syndrome. Am J Respir Crit Care Med 178(10):1066–1074PubMedCrossRef
21.
go back to reference Prevots DR, Shaw PA, Strickland D et al (2010) Non-tuberculous mycobacterial lung disease prevalence at four integrated healthcare delivery systems. Am J Respir Crit Care Med 182(7):970–976PubMedCrossRef Prevots DR, Shaw PA, Strickland D et al (2010) Non-tuberculous mycobacterial lung disease prevalence at four integrated healthcare delivery systems. Am J Respir Crit Care Med 182(7):970–976PubMedCrossRef
22.
go back to reference Sohn H, Kim HJ, Kim JM, Jung Kwon O, Koh WJ, Shin SJ (2009) High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease. Microb Pathog 47(6):321–328PubMedCrossRef Sohn H, Kim HJ, Kim JM, Jung Kwon O, Koh WJ, Shin SJ (2009) High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease. Microb Pathog 47(6):321–328PubMedCrossRef
23.
go back to reference Tatano Y, Yasumoto K, Shimizu T et al (2010) Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis- and cavitary-type diseases. Eur J Clin Microbiol Infect Dis 29(7):801–806PubMedCrossRef Tatano Y, Yasumoto K, Shimizu T et al (2010) Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis- and cavitary-type diseases. Eur J Clin Microbiol Infect Dis 29(7):801–806PubMedCrossRef
24.
go back to reference Aksamit TR (2002) Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med 23(3):643–653PubMedCrossRef Aksamit TR (2002) Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med 23(3):643–653PubMedCrossRef
25.
go back to reference Okumura M, Iwai K, Ogata H et al (2008) Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 47(16):1465–1472PubMedCrossRef Okumura M, Iwai K, Ogata H et al (2008) Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 47(16):1465–1472PubMedCrossRef
26.
go back to reference Baig IM, Saeed W, Khalil KF (2010) Post-tuberculous chronic obstructive pulmonary disease. J Coll Physicians Surg Pak 20(8):542–544PubMed Baig IM, Saeed W, Khalil KF (2010) Post-tuberculous chronic obstructive pulmonary disease. J Coll Physicians Surg Pak 20(8):542–544PubMed
27.
go back to reference Johnson MM, Waller EA, Leventhal JP (2008) Non-tuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med 14(3):203–210PubMedCrossRef Johnson MM, Waller EA, Leventhal JP (2008) Non-tuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med 14(3):203–210PubMedCrossRef
28.
go back to reference Koh WJ, Kwon OJ, Jeon K et al (2006) Clinical significance of non-tuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 129(2):341–348PubMedCrossRef Koh WJ, Kwon OJ, Jeon K et al (2006) Clinical significance of non-tuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 129(2):341–348PubMedCrossRef
29.
go back to reference Marras TK, Mehta M, Chedore P, May K, Al Houqani M, Jamieson F (2010) Non-tuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 188(4):289–299PubMedCrossRef Marras TK, Mehta M, Chedore P, May K, Al Houqani M, Jamieson F (2010) Non-tuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 188(4):289–299PubMedCrossRef
30.
go back to reference Shu CC, Lee LN, Wang JT, Chien YJ, Wang JY, Yu CJ (2010) Non-tuberculous mycobacterial pleurisy: an 8-year single-centre experience in Taiwan. Int J Tuberc Lung Dis 14(5):635–641PubMed Shu CC, Lee LN, Wang JT, Chien YJ, Wang JY, Yu CJ (2010) Non-tuberculous mycobacterial pleurisy: an 8-year single-centre experience in Taiwan. Int J Tuberc Lung Dis 14(5):635–641PubMed
Metadata
Title
Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns
Authors
Chin-Chung Shu
Chih-Hsin Lee
Chia-Lin Hsu
Jann-Tay Wang
Jann-Yuan Wang
Chong-Jen Yu
Li-Na Lee
The TAMI Group
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Lung / Issue 6/2011
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9321-4

Other articles of this Issue 6/2011

Lung 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.